您的位置: 首页 > 农业专利 > 详情页

Novel pyrimidine pyrrolo derivatives
专利权人:
NOVARTIS AG
发明人:
HENG, RICHARD,HOEGENAUER, ELIZABETH KATE,KOCH, GUIDO,PULZ, ROBERT ALEXANDER,VULPETTI, ANNA,WAELCHLI, RUDOLF
申请号:
ES12761655
公开号:
ES2548414T3
申请日:
2012.07.07
申请国别(地区):
ES
年份:
2015
代理人:
摘要:
A compound of formula (I) or a pharmaceutically acceptable salt thereof; ** Formula ** wherein, R 1 is hydrogen, C 1 -C 6 alkyl optionally substituted by hydroxy; R2 is hydrogen or halogen; R3 is hydrogen or halogen; R4 is hydrogen, R5 is phenyl optionally substituted by halogen; SF5; NR6R7; hydroxy; C1-C6 alkoxy; C1-C6 alkenyl; C1-C6 alkyl carbonyl; C1-C6 alkyl optionally substituted by hydroxy, halogen, or C1-C6 alkoxy; or C3-C6 cycloalkyl optionally substituted by halogen, hydroxy, or C1-C6 alkyl optionally substituted by halogen; or R5 is a 4-14 membered mono- or bicyclic heterocyclyl or heteroaryl ring system comprising 1, 2 or 3 heteroatoms selected from N, S and O with that ring being optionally substituted by halogen; hydroxy; C1-C6 alkoxy optionally substituted by hydroxy or halogen; or C1-C6 alkyl optionally substituted by hydroxy or halogen; or R4 and R5 together with the atoms to which they are attached form a piperidone ring, optionally comprising a fused phenyl ring, any such ring being optionally substituted by C1-C6 alkyl, C1-C6 alkoxy, or C3-C6 cycloalkyl, each of which substitution members may optionally be substituted by halogen or hydroxy; R6 and R7 are independently selected from hydrogen or C1-C6 alkyl; or R6 and R7 together with the nitrogen atom to which they are attached form a 4-8 membered saturated azacycloalkane ring, optionally substituted by halogen, hydroxy or C1-C6 alkyl; X is O, S (O) n where n is 0, 1 or 2, or is absent; where q is 2 or 3, and R10 is or X is CH or N; and R10 is hydrogen, hydroxy, -NR6R7, -CO-R11, -S (O) p-R12 where p is 1 or 2, R 11 is C1-C6 alkyl optionally substituted by hydroxy, cyano, halogen, carboxy or C1 -C6 alkoxycarbonyloxy; or NR6R7; and R12 is C1-C6 alkyl or NR6R7.Un compuesto de fórmula (I) o una sal farmacéuticamente aceptable del mismo;**Fórmula** en donde, R1 es hidrógeno, C1-C6 alquilo opcionalmente sustituido por hidroxi; R2 es hidrógeno o halógeno; R3 es hidrógeno o halógeno; R4 es hidrógeno, R5 es
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充